QQQ   267.64 (-0.99%)
AAPL   443.42 (-1.66%)
MSFT   206.16 (-1.00%)
FB   260.38 (-1.00%)
GOOGL   1,498.00 (+0.08%)
AMZN   3,121.05 (-0.86%)
NVDA   438.62 (-1.79%)
CGC   17.44 (-2.73%)
BABA   249.78 (+0.66%)
TSLA   1,392.00 (-1.87%)
GE   6.80 (+1.95%)
MU   48.65 (-1.02%)
AMD   78.80 (-4.18%)
T   30.45 (+0.83%)
F   7.32 (+3.24%)
ACB   10.12 (-0.98%)
GILD   68.06 (-0.66%)
NFLX   471.24 (-2.51%)
DIS   131.82 (+2.35%)
BAC   27.25 (+2.60%)
BA   186.10 (+3.73%)
QQQ   267.64 (-0.99%)
AAPL   443.42 (-1.66%)
MSFT   206.16 (-1.00%)
FB   260.38 (-1.00%)
GOOGL   1,498.00 (+0.08%)
AMZN   3,121.05 (-0.86%)
NVDA   438.62 (-1.79%)
CGC   17.44 (-2.73%)
BABA   249.78 (+0.66%)
TSLA   1,392.00 (-1.87%)
GE   6.80 (+1.95%)
MU   48.65 (-1.02%)
AMD   78.80 (-4.18%)
T   30.45 (+0.83%)
F   7.32 (+3.24%)
ACB   10.12 (-0.98%)
GILD   68.06 (-0.66%)
NFLX   471.24 (-2.51%)
DIS   131.82 (+2.35%)
BAC   27.25 (+2.60%)
BA   186.10 (+3.73%)
QQQ   267.64 (-0.99%)
AAPL   443.42 (-1.66%)
MSFT   206.16 (-1.00%)
FB   260.38 (-1.00%)
GOOGL   1,498.00 (+0.08%)
AMZN   3,121.05 (-0.86%)
NVDA   438.62 (-1.79%)
CGC   17.44 (-2.73%)
BABA   249.78 (+0.66%)
TSLA   1,392.00 (-1.87%)
GE   6.80 (+1.95%)
MU   48.65 (-1.02%)
AMD   78.80 (-4.18%)
T   30.45 (+0.83%)
F   7.32 (+3.24%)
ACB   10.12 (-0.98%)
GILD   68.06 (-0.66%)
NFLX   471.24 (-2.51%)
DIS   131.82 (+2.35%)
BAC   27.25 (+2.60%)
BA   186.10 (+3.73%)
QQQ   267.64 (-0.99%)
AAPL   443.42 (-1.66%)
MSFT   206.16 (-1.00%)
FB   260.38 (-1.00%)
GOOGL   1,498.00 (+0.08%)
AMZN   3,121.05 (-0.86%)
NVDA   438.62 (-1.79%)
CGC   17.44 (-2.73%)
BABA   249.78 (+0.66%)
TSLA   1,392.00 (-1.87%)
GE   6.80 (+1.95%)
MU   48.65 (-1.02%)
AMD   78.80 (-4.18%)
T   30.45 (+0.83%)
F   7.32 (+3.24%)
ACB   10.12 (-0.98%)
GILD   68.06 (-0.66%)
NFLX   471.24 (-2.51%)
DIS   131.82 (+2.35%)
BAC   27.25 (+2.60%)
BA   186.10 (+3.73%)
Log in

NYSE:STESteris Stock Price, Forecast & News

$160.20
+4.32 (+2.77 %)
(As of 08/11/2020 02:35 PM ET)
Add
Compare
Today's Range
$157.00
Now: $160.20
$160.25
50-Day Range
$148.33
MA: $154.97
$161.73
52-Week Range
$105.69
Now: $160.20
$168.98
Volume35,404 shs
Average Volume420,379 shs
Market Capitalization$13.61 billion
P/E Ratio33.31
Dividend Yield0.96%
Beta0.77
STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions. It also provides capital equipment install, maintain, upgrade, repair, and troubleshoot services. This segment provides its products and services to acute care hospitals, ambulatory surgery centers, and GI clinics. The Healthcare Specialty Services segment provides solutions and managed services, including instrument and endoscope repair and maintenance solutions; and custom process improvement consulting and outsourced sterile processing services to acute care hospitals and other healthcare settings. The Life Sciences segment offers formulated cleaning chemistries, barrier products, sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. The Applied Sterilization Technologies segment provides contract sterilization services using gamma, electron beam, and X-ray technologies, as well as ethylene oxide and hydrogen peroxide; and laboratory testing services. It operates a network of approximately 50 facilities. The company was founded in 1985 and is based in Derby, the United Kingdom.
Read More
Steris logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.3Community Rank: 2.1Dividend Strength: 3.3Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.68 out of 5 stars


Industry, Sector and Symbol

Industry Surgical appliances & supplies
Sub-IndustryHealth Care Equipment
SectorMedical
CUSIP85915210
Phone353-1232-2000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$3.03 billion
Cash Flow$8.33 per share
Book Value$40.17 per share

Profitability

Net Income$407.61 million

Miscellaneous

Employees13,000
Market Cap$13.61 billion
Next Earnings Date11/2/2020 (Estimated)
OptionableOptionable
$160.20
+4.32 (+2.77 %)
(As of 08/11/2020 02:35 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive STE News and Ratings via Email

Sign-up to receive the latest news and ratings for STE and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Steris (NYSE:STE) Frequently Asked Questions

How has Steris' stock price been impacted by Coronavirus (COVID-19)?

Steris' stock was trading at $145.25 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, STE shares have increased by 10.3% and is now trading at $160.20.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Steris?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Steris in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Steris
.

When is Steris' next earnings date?

Steris is scheduled to release its next quarterly earnings announcement on Monday, November 2nd 2020.
View our earnings forecast for Steris
.

How were Steris' earnings last quarter?

Steris PLC (NYSE:STE) issued its quarterly earnings data on Monday, August, 3rd. The medical equipment provider reported $1.31 earnings per share for the quarter, beating the Zacks' consensus estimate of $0.98 by $0.33. The medical equipment provider earned $668.90 million during the quarter, compared to the consensus estimate of $643.38 million. Steris had a return on equity of 16.24% and a net margin of 13.69%. The firm's quarterly revenue was down 4.0% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.23 EPS.
View Steris' earnings history
.

How often does Steris pay dividends? What is the dividend yield for Steris?

Steris announced a quarterly dividend on Monday, August 3rd. Stockholders of record on Thursday, August 27th will be paid a dividend of $0.40 per share on Thursday, September 24th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.00%. The ex-dividend date of this dividend is Wednesday, August 26th. This is a boost from Steris's previous quarterly dividend of $0.37.
View Steris' dividend history
.

What price target have analysts set for STE?

3 equities research analysts have issued twelve-month target prices for Steris' stock. Their forecasts range from $170.00 to $170.00. On average, they expect Steris' share price to reach $170.00 in the next twelve months. This suggests a possible upside of 6.1% from the stock's current price.
View analysts' price targets for Steris
.

Has Steris been receiving favorable news coverage?

News stories about STE stock have been trending neutral recently, according to InfoTrie Sentiment. The research firm rates the sentiment of news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Steris earned a news sentiment score of 0.2 on InfoTrie's scale. They also gave press coverage about the medical equipment provider a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the next several days.
View the latest news about Steris
.

Are investors shorting Steris?

Steris saw a increase in short interest in February. As of February 15th, there was short interest totaling 1,490,000 shares, an increase of 12.0% from the January 31st total of 1,330,000 shares. Based on an average trading volume of 792,700 shares, the short-interest ratio is presently 1.9 days. Approximately 1.8% of the shares of the company are sold short.
View Steris' Short Interest
.

Who are some of Steris' key competitors?

What other stocks do shareholders of Steris own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Steris investors own include Johnson & Johnson (JNJ), Visa (V), Gilead Sciences (GILD), Medtronic (MDT), Pfizer (PFE), AT&T (T), AbbVie (ABBV), Abbott Laboratories (ABT), Cisco Systems (CSCO) and Home Depot (HD).

Who are Steris' key executives?

Steris' management team includes the following people:
  • Mr. Walter M. Rosebrough Jr., CEO & Pres (Age 65)
  • Mr. Michael J. Tokich, Sr. VP, CFO & Director (Age 50)
  • Mr. Daniel A. Carestio, Chief Operating Officer (Age 46)
  • Mr. John Adam Zangerle, Sr. VP, Gen. Counsel, Sec. & Director (Age 52)
  • Dr. Adrian Vincent Coward, Sr. VP of Healthcare Specialty Services (Age 49)

What is Steris' stock symbol?

Steris trades on the New York Stock Exchange (NYSE) under the ticker symbol "STE."

Who are Steris' major shareholders?

Steris' stock is owned by many different retail and institutional investors. Top institutional investors include Bessemer Group Inc. (1.09%), Principal Financial Group Inc. (0.91%), Fisher Asset Management LLC (0.79%), Congress Asset Management Co. MA (0.74%), Villere ST Denis J & Co. LLC (0.72%) and Alta Capital Management LLC (0.59%). Company insiders that own Steris stock include Cary L Majors, Cynthia L Feldmann, Daniel A Carestio, Jacqueline B Kosecoff, John Adam Zangerle, Karen L Burton, Kathleen Bardwell, Loyal W Wilson, Michael B Wood, Michael J Tokich, Mohsen Sohi, Renato Tamaro, Richard Martin Steeves, Walter M Rosebrough Jr and Walter M Rosebrough, Jr.
View institutional ownership trends for Steris
.

Which major investors are selling Steris stock?

STE stock was sold by a variety of institutional investors in the last quarter, including Fisher Asset Management LLC, Assenagon Asset Management S.A., Robeco Institutional Asset Management B.V., Frontier Capital Management Co. LLC, GW&K Investment Management LLC, New York State Common Retirement Fund, Arizona State Retirement System, and WINTON GROUP Ltd. Company insiders that have sold Steris company stock in the last year include John Adam Zangerle, Mohsen Sohi, Renato Tamaro, and Richard Martin Steeves.
View insider buying and selling activity for Steris
.

Which major investors are buying Steris stock?

STE stock was purchased by a variety of institutional investors in the last quarter, including TimesSquare Capital Management LLC, Retirement Systems of Alabama, Principal Financial Group Inc., Bessemer Group Inc., Alta Capital Management LLC, McCollum Christoferson Group LLC, Princeton Portfolio Strategies Group LLC, and Envestnet Asset Management Inc..
View insider buying and selling activity for Steris
.

How do I buy shares of Steris?

Shares of STE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Steris' stock price today?

One share of STE stock can currently be purchased for approximately $160.20.

How big of a company is Steris?

Steris has a market capitalization of $13.61 billion and generates $3.03 billion in revenue each year. The medical equipment provider earns $407.61 million in net income (profit) each year or $5.64 on an earnings per share basis. Steris employs 13,000 workers across the globe.

What is Steris' official website?

The official website for Steris is www.steris.com.

How can I contact Steris?

Steris' mailing address is 70 Sir John Rogerson`s Quay, Dublin L2, D02 R296. The medical equipment provider can be reached via phone at 353-1232-2000 or via email at [email protected]

This page was last updated on 8/11/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.